New technologies are shortening the diagnostic process.
NYS Entity Status
NYS Filing Date
FEBRUARY 10, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2014 - MODERN MEDICAL DIAGNOSTICS, PLLC
AROUND THE WEB
- Can the Diagnostic Process Be Shortened to Minutes?
Friday Jun 9, 2017
- Traces of Crime: How New York’s DNA Techniques Became Tainted
By LAUREN KIRCHNER - Monday Sep 4, 2017
The city’s medical examiner has been a pioneer in analyzing complex DNA samples. But two methods were recently discontinued, raising questions about thousands of cases.
- Investors bet big on AI for health diagnostics
By Jonathan Norris, Silicon Valley Bank - Saturday Aug 5, 2017
GUEST: We’re seeing a new wave of venture investments in healthtech companies — especially those with strong artifical intelligence and machine learning components. Led by some of the world’s largest biopharma companies and tech-focused venture capitalists, these investments are backing efforts to speed drug discovery, improve tests and treatments, and further medical research. For now, most […]
- Man Killed in 9/11 Attacks Is Identified by DNA Testing
By ASHLEY SOUTHALL - Monday Aug 7, 2017
The man, whose name was withheld by officials at his family’s request, was the first Sept. 11 victim to be identified in more than two years.
- An Insider’s Guide to Bridging the Biotech Gender Gap
By Robin Toft - Tuesday Aug 8, 2017
As an executive recruiter focused solely on life sciences, I’m among the first to acknowledge the industry’s gender gap. Of the 20 largest pharmaceutical companies around the world, only one has a woman at the helm—and GSK named Emma Natasha Walmsley as CEO less than five months ago. Among biotech executive leadership teams, women make […]
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]